Warfarin and Dental Treatment

Drug: Warfarin

German terms: Warfarin, Vitamin-K-Antagonist, orale Antikoagulation, INR-Wert

Category: Vitamin K antagonist anticoagulant

Dental relevance: Bleeding-risk assessment before invasive dental procedures, especially extraction, periodontal surgery, implant surgery, and deep scaling.

Key principle: For many dental procedures, warfarin is usually continued when the INR is within the safe treatment range. Stopping warfarin without medical advice can expose the patient to serious thromboembolic risk.

This article is for dental education only. Do not tell a patient to stop warfarin without coordination with the prescribing clinician or anticoagulation service. The danger of thrombosis, stroke, pulmonary embolism, or valve thrombosis may be greater than the risk of manageable dental bleeding. Dental care should be planned using the current INR, procedure bleeding risk, local haemostatic measures, and patient-specific medical factors.

Warfarin reduces blood clotting by inhibiting vitamin K-dependent clotting factor production. Because its effect varies between patients and over time, the International Normalized Ratio, or INR, is used to estimate anticoagulation intensity.

In dental practice, the key question is not simply “Does the patient take warfarin?” The key question is: What is the INR, what procedure is planned, and can bleeding be controlled locally?

Many routine invasive dental procedures can be performed without interrupting warfarin when the INR is below the recommended threshold and good local haemostasis is used.

• Best dental approach: continue warfarin for most routine dental care when INR is acceptable and local measures are available.
• Main dental risk: postoperative bleeding after invasive procedures.
• Main medical risk if stopped: thromboembolism, stroke, valve thrombosis, pulmonary embolism, or recurrence of the original clotting problem.
• Key lab value: INR.
• Clinical priority: check INR timing, procedure bleeding risk, drug interactions, and local haemostatic plan.

Warfarin is a vitamin K antagonist. It reduces the production of vitamin K-dependent clotting factors, which slows clot formation. This is useful for preventing dangerous clots but increases bleeding tendency during and after invasive dental procedures.

• Effect monitoring: INR measures how prolonged clotting is compared with normal.
• Higher INR: generally means higher bleeding risk.
• Lower INR: may mean less anticoagulation but more thrombotic risk if below therapeutic range.
• Dental implication: treatment planning should use the most recent INR and the planned procedure bleeding risk.

A widely used dental rule from SDCEP guidance is: if the patient takes warfarin or another vitamin K antagonist and the INR is below 4, treat without interrupting anticoagulant medication, using appropriate local haemostatic measures.

• INR below 4: routine invasive dental treatment can often proceed with local bleeding control.
• INR 4 or above: delay elective invasive treatment and contact the anticoagulation service or prescribing clinician.
• INR timing: ideally check INR no more than 24 hours before treatment; if INR is stable, some guidance allows up to 72 hours.
• Important: local rules may differ, so follow the guidance used in your country and clinic.

• Usually low bleeding risk: examination, radiographs, impressions, simple restorations, supragingival scaling, local anesthesia by infiltration, and non-surgical endodontics.
• Higher bleeding risk: extraction, periodontal surgery, implant placement, surgical endodontics, subgingival scaling/root surface instrumentation, biopsies, and flap procedures.
• Plan carefully: limit the surgical area when possible, use staged appointments, and avoid starting extensive surgery late in the day or before weekends.
• Do not assume: a simple extraction is always simple in an anticoagulated patient. Surgical difficulty and local anatomy matter.

Most dental bleeding in warfarin patients should be controlled locally. Planning local haemostasis is safer than stopping anticoagulation unnecessarily.

• Use atraumatic technique and remove granulation tissue where appropriate.
• Apply firm pressure with gauze for an adequate time.
• Use local haemostatic packing when indicated, such as oxidized cellulose, gelatin sponge, or collagen-based material according to local availability.
• Use sutures when needed to stabilize the clot and wound margins.
• Consider tranexamic acid mouthwash or soaked gauze when locally recommended or prescribed.
• Give clear written postoperative instructions and emergency contact advice.
• Review promptly if bleeding is persistent or recurrent.

• Confirm the patient is actually taking warfarin and ask why it was prescribed.
• Ask for the most recent INR and check whether anticoagulation has been stable.
• Schedule treatment early in the day and early in the week when possible.
• Limit the number of extractions per visit if bleeding risk or surgical complexity is high.
• Use careful local anesthesia and avoid traumatic surgery.
• Prepare local haemostatic materials before starting.
• Check haemostasis before discharge.
• Provide written instructions: bite pressure, avoid vigorous rinsing, avoid smoking, avoid alcohol, and know when to call.

• INR is 4 or above for elective invasive dental treatment.
• INR is unknown and invasive treatment is planned.
• The patient reports unstable INR, recent dose changes, missed doses, or recent bleeding episodes.
• The patient has liver disease, thrombocytopenia, bleeding disorder, renal failure, cancer therapy, or other additional bleeding risks.
• The procedure is extensive, surgical, or difficult to control locally.
• The patient is also taking antiplatelets, NSAIDs, SSRIs/SNRIs, corticosteroids, or interacting antibiotics/antifungals.
• The patient has a mechanical heart valve, recent thromboembolism, or very high thrombotic risk and someone suggests stopping warfarin.
• Postoperative bleeding is persistent despite correct local measures.

Warfarin has many clinically important drug interactions. Dental prescriptions can increase bleeding risk by increasing anticoagulant effect or by adding platelet/GI bleeding risk.

• Miconazole oral gel: important interaction with warfarin; avoid or consult because INR can rise dangerously.
• Metronidazole: can increase warfarin effect; check guidance and coordinate INR monitoring.
• Fluconazole: can increase warfarin effect; use only when clearly indicated with monitoring advice.
• Macrolides: erythromycin and clarithromycin can interact with warfarin.
• NSAIDs and aspirin: increase bleeding risk; avoid unless specifically justified.
• Paracetamol/acetaminophen: often preferred for dental pain, but prolonged high-dose use may still affect INR in some patients.

• Pain control: paracetamol/acetaminophen is often the first choice for short-term dental pain when appropriate.
• Avoid casual NSAIDs: ibuprofen, naproxen, diclofenac, and aspirin can increase bleeding or gastric risk.
• Antibiotics: prescribe only when indicated; avoid unnecessary antibiotics because infection and antibiotics can both destabilize INR.
• High-risk interactions: metronidazole, miconazole, fluconazole, erythromycin, and clarithromycin require caution or alternatives.
• INR monitoring: if an interacting antibiotic or antifungal is unavoidable, advise coordination with the anticoagulation service for INR monitoring.

• Telling the patient to stop warfarin without medical coordination.
• Performing an extraction without knowing the recent INR.
• Thinking “warfarin patient” automatically means “no dental extraction.”
• Starting metronidazole or miconazole oral gel without considering warfarin interaction.
• Using NSAIDs for postoperative pain without checking bleeding and gastric risks.
• Ignoring local haemostatic measures and relying only on medication changes.
• Doing extensive surgery late in the day or before a weekend.
• Discharging the patient before haemostasis is stable.
• Failing to give written postoperative instructions.
• Not planning review if bleeding continues.

• Bite firmly on the gauze exactly as instructed.
• Do not rinse vigorously on the first day unless instructed.
• Avoid smoking, alcohol, spitting, and strenuous exercise during the early clot period.
• Use the prescribed pain medicine exactly as directed.
• Do not take over-the-counter aspirin or NSAIDs unless the dentist or doctor says it is safe.
• If bleeding restarts, place clean gauze and bite firmly for the instructed time.
• Contact the clinic if bleeding does not slow, if clots keep filling the mouth, or if the patient feels weak or dizzy.
• Keep taking warfarin as normally instructed unless the anticoagulation clinician gives different advice.

In warfarin patients, the safest dental plan is usually not “stop the drug.” It is “know the INR, reduce surgical trauma, control bleeding locally, avoid interacting prescriptions, and give clear follow-up instructions.”

• Bleeding that does not slow after repeated firm pressure.
• Large clots repeatedly filling the mouth.
• Dizziness, fainting, weakness, paleness, or signs of significant blood loss.
• Bleeding with airway concern or inability to manage saliva and blood.
• INR known to be high with active dental bleeding.
• Facial swelling, fever, dysphagia, trismus, or spreading odontogenic infection.
• Recent stroke, thromboembolism, mechanical valve concern, or medical instability.
• Patient has taken interacting medication and develops unusual bleeding or bruising.

• Apixaban
• Rivaroxaban
• Dabigatran
• Edoxaban
• Aspirin as antiplatelet therapy
• Clopidogrel
• Tranexamic acid mouthwash
• Dental extraction bleeding management
• Antibiotic interactions in dentistry
• Local haemostasis

Warfarin is a vitamin K antagonist anticoagulant that requires INR-based dental planning. For many routine invasive dental procedures, warfarin is not interrupted if the INR is below the recommended treatment threshold, commonly below 4 in SDCEP guidance, and local haemostatic measures are used. The dentist should check INR timing, procedure bleeding risk, local control options, interacting prescriptions, and additional medical bleeding risks. Elective invasive treatment should be delayed when the INR is too high or unknown. Local measures such as pressure, sutures, haemostatic packing, staged treatment, and clear postoperative instructions are central. Avoid casual prescribing of interacting antifungals, antibiotics, NSAIDs, or aspirin for pain. The key message is simple: do not stop warfarin casually; manage dental bleeding locally and coordinate with the anticoagulation team when risk is elevated.